Does RISANKIZUMAB-RZAA Cause Memory impairment? 382 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 382 reports of Memory impairment have been filed in association with RISANKIZUMAB-RZAA. This represents 0.6% of all adverse event reports for RISANKIZUMAB-RZAA.
382
Reports of Memory impairment with RISANKIZUMAB-RZAA
0.6%
of all RISANKIZUMAB-RZAA reports
1
Deaths
94
Hospitalizations
How Dangerous Is Memory impairment From RISANKIZUMAB-RZAA?
Of the 382 reports, 1 (0.3%) resulted in death, 94 (24.6%) required hospitalization, and 1 (0.3%) were considered life-threatening.
Is Memory impairment Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 382 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Memory impairment?
DIMETHYL (4,788)
TOFACITINIB (3,750)
ADALIMUMAB (3,675)
INTERFERON BETA-1A (3,468)
ETANERCEPT (3,359)
NATALIZUMAB (3,024)
PREGABALIN (2,954)
FINGOLIMOD (2,623)
SACUBITRIL\VALSARTAN (2,265)
METHOTREXATE (2,205)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Memory impairment Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA